I have previously conducted research on an innovative inorganic nanocrystalline hydrogel imbued with antimicrobial properties designed for addressing prevalent skin infections, notably those caused by S. aureus and E. coli pathogens.

Presently, our focus lies on the development of lateral flow assay (LFA) platforms tailored for detecting Hepatitis E virus and Norovirus infections. Furthermore, we are actively engaged in the advancement of rapid qualitative tests for diagnosing HIV and Syphilis with enhanced efficiency and accuracy.